Search images on Google      Product Monograph

Active Ingredients:

• ceftolozane (ceftolozane sulfate), 1 G/VIAL
• tazobactam (tazobactam sodium), 0.5 G/VIAL

DIN: 02446901

Dosage Form(s): POWDER FOR SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: SINGLE USE VIALS

Schedule: Prescription

Company: MERCK CANADA INC  –  official site

ATC:

• J01 - ANTIBACTERIALS FOR SYSTEMIC USE (ATC, WHO, Wiki)
• J01D - OTHER BETA-LACTAM ANTIBACTERIALS (ATC, WHO)
• J01DI - Other cephalosporins (ATC, WHO)
• J01DI54 - CEFTOLOZANE AND BETA-LACTAMASE INHIBITOR (WHO)

Packaging:

• Package size unit: No information
• Package type: No information
• Package size: No information
• Product information: 11.4ML (RECONST.) (1.5G)

 

External Links for Zerbaxa:

Search on Google

• Zerbaxa side effects
• Zerbaxa dosage
• ceftolozane side effects
• ceftolozane dosage
• tazobactam side effects
• tazobactam dosage

Merck Canada Inc

Go to Merck website to see drug product details. Sometimes you can find zerbaxa photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.